These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2891593)

  • 1. Characterization of the submerged growth of Moraxella bovis.
    Mandl M; Simon V; Horavová P; Smíd B; Standara S
    Folia Microbiol (Praha); 1987; 32(5):382-7. PubMed ID: 2891593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of colonies of Moraxella bovis by plate epi-immunofluorescence.
    McDonald TJ; Pugh GW
    Am J Vet Res; 1979 Nov; 40(11):1652-3. PubMed ID: 43106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth requirements for Moraxella bovis.
    Riley WT
    Vet Microbiol; 1984 Oct; 9(6):593-8. PubMed ID: 6150572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defined medium for Moraxella bovis.
    Juni E; Heym GA
    Appl Environ Microbiol; 1986 Oct; 52(4):966-8. PubMed ID: 3777935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM
    Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General approach to bacterial nutrition: growth factor requirements of Moraxella nonliquefaciens.
    Juni E; Heym GA; Bradley RA
    J Bacteriol; 1984 Dec; 160(3):958-65. PubMed ID: 6438065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of an Escherichia coli mutant deficient in respiration.
    Futatsugi L; Saito H; Kakegawa T; Kobayashi H
    FEMS Microbiol Lett; 1997 Nov; 156(1):141-5. PubMed ID: 9368373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
    Ozturk SS; Palsson BO
    Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence of Moraxella bovis to cell cultures of bovine origin.
    Annuar BO; Wilcox GE
    Res Vet Sci; 1985 Sep; 39(2):241-6. PubMed ID: 2866569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q pili enhance the attachment of Moraxella bovis to bovine corneas in vitro.
    Ruehl WW; Marrs C; Beard MK; Shokooki V; Hinojoza JR; Banks S; Bieber D; Mattick JS
    Mol Microbiol; 1993 Jan; 7(2):285-8. PubMed ID: 8095318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the virulence of various strains of Moraxella bovis.
    Pugh GW; Hughes DE
    Can J Comp Med; 1970 Oct; 34(4):333-40. PubMed ID: 4249096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anti-Moraxella bovis pili immunoglobulin-A in tears following intranasal vaccination of cattle.
    Zbrun MV; Zielinski GC; Piscitelli HC; Descarga C; Urbani LA; Defain Tesoriero MV; Hermida L
    Res Vet Sci; 2012 Aug; 93(1):183-9. PubMed ID: 21664636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphogenetic expression of Moraxella bovis fimbriae (pili) in Pseudomonas aeruginosa.
    Beard MK; Mattick JS; Moore LJ; Mott MR; Marrs CF; Egerton JR
    J Bacteriol; 1990 May; 172(5):2601-7. PubMed ID: 1970564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious bovine keratoconjunctivitis: enhancement of Moraxella bovis pili immunogenicity with diphtheria-tetanus toxoids and pertussis vaccine.
    Pugh GW; Kopecky KE; McDonald TJ
    Am J Vet Res; 1984 Apr; 45(4):661-5. PubMed ID: 6145379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of type 4 pilin genes and the site-specific recombinase gene, piv, in Moraxella lacunata and Moraxella bovis.
    Heinrich DW; Glasgow AC
    J Bacteriol; 1997 Dec; 179(23):7298-305. PubMed ID: 9393693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis.
    Billson FM; Hodgson JL; Egerton JR; Lepper AW; Michalski WP; Schwartzkoff CL; Lehrbach PR; Tennent JM
    FEMS Microbiol Lett; 1994 Nov; 124(1):69-73. PubMed ID: 8001772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.